Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative Treatment of Non-Complicated Acute Appendicitis in Children
2025-520496-19-00Phase 4Authorised
- Sponsor
- Rīga Stradiņš University
- Start
- Jan 2025
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of amoxicillin, clavulanic acid, metronidazole, ampicillin and ceftazidime in acute appendicitis, sponsored by Rīga Stradiņš University. Primary endpoint: Clinical and economic efficiency and safety over core treatment period. Planned start Jan 2025; status: authorised.
02
Drugs
amoxicillinclavulanic acidmetronidazoleampicillinceftazidime
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on 2025-520496-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520496-19-00.